Market Overview

Morning Market Losers

Share:
Related PPHM
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Avid Bioservices Announces Expansion Of cGMP Manufacturing Capacity
Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in Combination With Sorafenib ... (GuruFocus)
Related QCOR
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio
Why A 5% To 10% Market Correction May Be In The Cards
John Hussman Purchases 36 New Stocks in Q3 2014 (GuruFocus)

Peregrine Pharmaceuticals (NASDAQ: PPHM) fell 74.58% to $1.37 at 10:55 am. Peregrine Pharmaceuticals reported that it discovered major discrepancies in its Phase II trial data of bavituximab.

Questcor Pharmaceuticals (NASDAQ: QCOR) shares dipped 31.50% to $20.64. Analysts at ThinkEquity downgraded Questcor from “buy” to “hold.”

Daegis (NASDAQ: DAEG) dropped 19.08% to $1.40. Daegis' trailing-twelve-month ROE is -110.48%.

Dialogic (NASDAQ: DLGC) shares lost 19% to $2.60. Dialogic shares have dipped 72.56% over the past 52 weeks, while the S&P 500 index has gained 25.57% in the same period.

Posted-In: Morning Market LosersNews Movers & Shakers Intraday Update Markets

 

Related Articles (DAEG + DLGC)

Around the Web, We're Loving...

Get Benzinga's Newsletters